{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:07:59Z","timestamp":1761512879116},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,12,18]],"date-time":"2007-12-18T00:00:00Z","timestamp":1197936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Recent data indicate that statins could offer coronary artery disease (CAD) benefit even by mechanisms beyond lipid lowering. Genetic influence has been shown for some antithrombotic actions of statins via oxidized\u2010low\u2010density lipoprotein cholesterol (ox\u2010LDL) receptors and nitric oxide synthase (NOS) activity modulation. The present study was designed to evaluate the influence of ox\u2010LDL lectin\u2010like receptor\u20101 (LOX\u20101) and NOS polymorphisms in the incidence of cardiovascular events in pure hypercholesterolaemic subjects during statin treatment.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> A prospective 4\u2010year study involving 1039 event\u2010free subjects (643 males, 396 females) treated with atorvastatin (10\u201340\u00a0mg\u00a0day<jats:sup>\u22121<\/jats:sup>) to reach the appropriate Adult Treatment Panel\u2010III LDL target of 3\u00b736\u00a0mmol\u00a0L<jats:sup>\u22121<\/jats:sup>. Enrolled subjects were evaluated every 6 months or at a clinical event. LOX\u20101 3\u2032UTR\/T\u2010C and NOS G894T polymorphisms were detected by allelic discrimination assays (polymerase chain reaction), lipid profile by enzymatic\u2010colorimetric method, ox\u2010LDL by enzyme linked immunosorbent assay, platelet activation by P\u2010selectin (P\u2010sel) expression (FACScan), NOS activity (by intracellular citrullin recovery) and homocysteine (high performance liquid chromatography), C\u2010reactive protein (CRP) by sensitive nephelometric technique.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> LOX\u20101 3\u2032UTR\/T showed the strongest association with events in the whole cohort with respect to each other variable including LDL reduction and NOS G894T (OR 4\u00b790, 95% CI 3\u00b719\u20136\u00b798, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b700001). Smoking influenced events in LDL\u2010targeted subjects (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00\u00b70001). Ox\u2010LDL and P\u2010sel were better indicators than LDL or other variables according to 3\u2032UTR\/C genotype regardless of the magnitude of LDL reduction (OR 4\u00b721, 95% CI 2\u00b729\u20136\u00b770 <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b70001).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> LOX\u20101 polymorphisms could influence statin effectiveness in CAD prevention by induction of sensitivity to antithrombotic mechanisms such as antiplatelet activity.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2007.01891.x","type":"journal-article","created":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T09:47:52Z","timestamp":1284544072000},"page":"11-16","source":"Crossref","is-referenced-by-count":8,"title":["Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia"],"prefix":"10.1111","volume":"38","author":[{"given":"L.","family":"Puccetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Pasqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pastorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Palazzuoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Acampa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Auteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2006.01.004"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.08.011"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568006043586161"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.03.012"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.12.933"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.14.1515"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","unstructured":"PuccettiL PasquiAl BruniF PastorelliM CianiF PalazzuoliAet\u00a0al.Lectin\u2010like oxidized\u2010LDL rerecptor\u20101 (LOX\u20101) polymorphisms influence cardiovascular events rate during statin treatment.Int J Cardiol2006 October 12[Epub ahead of print].","DOI":"10.1016\/j.ijcard.2006.07.045"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adults treatment panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","author":"Expert Committee on the Diagnosis","year":"2003","journal-title":"Diabetes Care"},{"key":"e_1_2_6_12_2","first-page":"2560","article-title":"The JNC 7 report","volume":"289","author":"The seventh report of the Joint National Committee on prevention, detection evaluation","year":"2003","journal-title":"JAMA"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/hy1101.092967","article-title":"Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease","volume":"38","author":"Jeerooburkhan N","journal-title":"Hypertension"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1160\/TH05-05-0317","article-title":"Early Anti\u2010thrombotic and anti\u2010inflammatory actions of statins and fibrates. Time for adjuvant therapy in acute coronary syndromes?","volume":"94","author":"Damas JK","year":"2005","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.575241"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(99)00293-2"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2007.01891.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2007.01891.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:54:22Z","timestamp":1697453662000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2007.01891.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,18]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1111\/j.1365-2362.2007.01891.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2007.01891.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,18]]}}}